Penza “Biosintez” listed among drug manufacturers leading in production of defective goods
Print
Moscow, 12 February 2014. PenzaNews. Penza enterprise “Biosintez” took the ninth place in the list of drug manufacturers the products of which received the highest number of complaints in 2013.
© PenzaNewsBuy the photo
The list of companies-leaders in terms of defective production was compiled by the Federal Service for Health Supervision.
The first three lines belong to LLC “Asfarma,” JSC “EKOlab,” and JSC “Vifiteh.”
Also the list includes Federal State Unitary Enterprise “Armavir biological factory,” LLC “Iodine technology and marketing,” JSC “Tyumen chemical-pharmaceutical plant,” JSC “Uralbiofarm,” JSC “PKF-Obnovlenie,” and LLC “Bryntsalov-A.”
The explanatory note to the study states that “Biosintez” was included in the list based on the evaluation of the following parameters — “Description,” “Microbiological purity,” “Pyrogenicity,” “Disintegration,” and “Dissolution.”